scholarly journals A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen

2007 ◽  
Vol 13 (11) ◽  
pp. 3286-3292 ◽  
Author(s):  
Andrew M. Scott ◽  
Niall Tebbutt ◽  
Fook-Thean Lee ◽  
Tina Cavicchiolo ◽  
Zhanqi Liu ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Humanized Monoclonal Antibody ◽  
Lewis Y

Phase I trial of hu3S193 in patients with advanced epithelial cancers which express the Lewis-y antigen

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2567-2567
Author(s):  
A. M. Scott ◽  
N. Tebbutt ◽  
F.-T. Lee ◽  
T. Cavicchiolo ◽  
Z. Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Lewis Y

scholarly journals Phase ii clinical trial, testing the efficacy of a humanized monoclonal antibody against the Lewis-Y antigen (Le y)

Mastology ◽  
2018 ◽  
Vol 28 (s1) ◽  
pp. 11-11
Author(s):  
Laura Testa ◽  
◽  
Ruffo Freitas- Junior ◽  
Sergio V Serrano ◽  
Roberto J Arai ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Monoclonal Antibody ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Lewis Y Antigen ◽  
Humanized Monoclonal Antibody ◽  
Trial Testing ◽  
Lewis Y

Phase I trial of hu3S193 in patients with advanced epithelial cancers which express the Lewis-y antigen

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2567-2567 ◽  
Author(s):  
A. M. Scott ◽  
N. Tebbutt ◽  
F.-T. Lee ◽  
T. Cavicchiolo ◽  
Z. Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Epithelial Cancers ◽  
Lewis Y Antigen ◽  
Lewis Y

scholarly journals Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

2010 ◽  
Vol 25 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Andres Forero-Torres ◽  
Jatin Shah ◽  
Tina Wood ◽  
James Posey ◽  
Ronda Carlisle ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Death Receptor ◽  
Death Receptor 5 ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting

scholarly journals A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

2019 ◽  
Vol 37 (5) ◽  
pp. 1061-1074 ◽  
Author(s):  
Toshihiko Doi ◽  
Takeshi Aramaki ◽  
Hirofumi Yasui ◽  
Kei Muro ◽  
Masafumi Ikeda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients ◽  
Humanized Monoclonal Antibody ◽  
Antibody Targeting
Sign in / Sign up

Export Citation Format

Share Document